TheAnswerPage

APRIL 9, 2021

Currently and historically, the most common qualifying condition reported by medical marijuana patients is chronic pain. In fact, according to Boehnke et al’s analysis of 2016 data, chronic pain was the qualifying condition reported by medical marijuana patients nearly 65 percent of the time.

Chronic Pain 53

Chronic Pain Conditions Data Patients 53

CannaMD

DECEMBER 8, 2020

Between 2016-2018, despite rapidly expanding state legalization, there was a slight increase in marijuana-related arrests year over year. In 2019, for example, FBI data shows 495,871 arrests made for violent crime – compared to the 500,395 individuals who were arrested for marijuana possession with no additional charges.

Marijuana 105

Marijuana Chronic Pain Treatment Legalization 105

TheAnswerPage

JUNE 9, 2022

Currently and historically the most common qualifying condition reported by medical marijuana patients is chronic pain. In fact, according to an analysis by Boehnke et al, chronic pain was the qualifying condition reported by medical marijuana patients nearly 65 percent of the time (according to 2016 data).

Chronic Pain 45

Chronic Pain Conditions Data Patients 45

TheAnswerPage

MARCH 3, 2022

Currently and historically the most common qualifying condition reported by medical marijuana patients is chronic pain. In fact, according to an analysis by Boehnke et al, chronic pain was the qualifying condition reported by medical marijuana patients nearly 65 percent of the time (according to 2016 data).

Chronic Pain 45

Chronic Pain Conditions Data Patients 45

Cannabis Law Report

AUGUST 23, 2022

Spotlight PA sought that data to better understand the impact of the agency’s unusual and controversial decision to endorse cannabis as a treatment option for opioid use disorder. Qualifying conditions include anxiety disorders, severe chronic pain and epilepsy. It’s a very significant case,” Melewsky told Spotlight PA. “And

Data 52

Data Treatment Patients Chronic Pain 52

TheAnswerPage

OCTOBER 5, 2020

Currently and historically the most common qualifying condition reported by medical marijuana patients is chronic pain. In fact, according to an analysis by Boehnke et al, chronic pain was the qualifying condition reported by medical marijuana patients nearly 65 percent of the time (according to 2016 data).

Chronic Pain 40

Chronic Pain Conditions Data Patients 40

Healer

MARCH 26, 2021

This article from the Portland Press Herald includes information from a study by Dr. Sulak in 2016 that showed 85% of 525 of his practice’s patients reported a decrease in or cessation of opioid use when using medical cannabis. Additional resources on cannabis and opioids: Published data on cannabis treatment to reduce opioid usage.

Chronic Pain 52

Chronic Pain Therapy Data Patients 52

Healer

MARCH 26, 2021

This article from the Portland Press Herald includes information from a study by Dr. Sulak in 2016 that showed 85% of 525 of his practice’s patients reported a decrease in or cessation of opioid use when using medical cannabis. Additional resources on cannabis and opioids: Published data on cannabis treatment to reduce opioid usage.

Chronic Pain 52

Chronic Pain Therapy Data Patients 52

Healer

MARCH 26, 2021

This article from the Portland Press Herald includes information from a study by Dr. Sulak in 2016 that showed 85% of 525 of his practice’s patients reported a decrease in or cessation of opioid use when using medical cannabis. Additional resources on cannabis and opioids: Published data on cannabis treatment to reduce opioid usage.

Chronic Pain 52

Chronic Pain Therapy Data Patients 52

TheAnswerPage

JULY 10, 2022

What was the second most common condition for medical cannabis licensure through 2016? PTSD was not the second most common condition for medical licensure in 2016. According to an analysis of data from U.S. Trends in Registration for Medical Cannabis and Reasons for Use From 2016 to 2020: An Observational Study.

Chronic Pain 40

Chronic Pain Conditions Data Patients 40

TheAnswerPage

DECEMBER 6, 2020

The findings of multiple randomized controlled trials (RCTs) indicate that cannabinoids effectively treat chronic pain. Do cannabinoids effectively treat the chronic pain associated with fibromyalgia? See Answer. See Answer.

Chronic Pain 40

Chronic Pain Cannabinoids Pharmaceutical Data 40

TheAnswerPage

JUNE 28, 2020

The findings of multiple RCTs indicate that cannabinoids effectively treat chronic pain. Do cannabinoids effectively treat the chronic pain associated with fibromyalgia? Note: The data from the 2019 study could not be used to extrapolate the long-term effects of cannabinoids on fibromyalgia-associated pain.).

Chronic Pain 40

Chronic Pain Cannabinoids Pharmaceutical Data 40

Cannabis Law Report

MAY 10, 2022

First academic study of national medicinal cannabis data. Of the 248,000 scripts approved for Australians since inception of national medicinal cannabis scheme in 2016, many related to conditions for which the drug has limited evidence of efficacy, a new University of Sydney study shows. This usage has not been extensively explored.”.

Medicine 52

Medicine Clinical Trials Sleep Data 52

Cannabis Law Report

FEBRUARY 17, 2020

Let’s highlight the Florida Medical Marijuana timeline between 2016 and 2019 , leading up to the future case hearing and ultimate decision, and attempt to decipher what all this fuss is about. . CANNABIS PRIMER. Glossary of Marijuana Terminologyvia CannaInsider.com. Americans for Safe Access.org. Amyotrophic Lateral Sclerosis (ALS).

Dispensary 76

Dispensary Patients Agriculture Conditions 76

Canna Care Docs

JULY 29, 2019

A recently released study out of New York University, supported by the National Institute on Drug Abuse, looked at data from the National Survey on Drug Use and Health, an annual survey of 70,000 Americans of all ages. Researchers found that in the 2015-2016 survey, 9% of adults ages 50 to 64, and 2.9% Gluchacki said.

Chronic Pain 53

Chronic Pain Sleep Education Patients 53

SpeedWeed

JULY 10, 2021

According to the governor, the new law acts on the recommendations made by the Pennsylvania Department of Health to revise the Medical Marijuana Act, which was signed into law in April 2016. In particular, the expansion of the caregiver program is quite important to us.

Access 52

Access Research and Development Programs Chronic Pain 52

SpeedWeed

JULY 6, 2021

According to the governor, the new law acts on the recommendations made by the Pennsylvania Department of Health to revise the Medical Marijuana Act, which was signed into law in April 2016. In particular, the expansion of the caregiver program is quite important to us.

Research and Development 52

Research and Development Programs Chronic Pain Legislation 52

SpeedWeed

JULY 5, 2021

According to the governor, the new law acts on the recommendations made by the Pennsylvania Department of Health to revise the Medical Marijuana Act, which was signed into law in April 2016. In particular, the expansion of the caregiver program is quite important to us.

Research and Development 52

Research and Development Programs Chronic Pain Legislation 52

Sensi Seeds

JANUARY 4, 2019

Its arguments are that there is insufficient clinical evidence about the medicinal benefits of cannabis, and that available data on indications, potency (THC, CBD levels) drug interactions and adverse effects are still too few.

Medicine 75

Medicine Research and Development Patients Programs 75

TheAnswerPage

JANUARY 11, 2022

As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1).

Patients 98

Patients Education Marijuana Therapy 98

Veriheal

JULY 5, 2021

The self-reported data was logged between June 6, 2016, and July 8, 2019. The UNM researchers noted that, since nausea is just one symptom, CBD may be a better option for relieving the symptoms associated with other types of medical conditions, such as epilepsy and chronic pain.

THC 52

THC CBD Treatment Cannabinoids 52

Cannabis Law Report

NOVEMBER 24, 2021

Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. At the same time, the outlook on cannabis research data is largely positive. Legalisation occurred in Australia in 2016. 2016 ; Sznitman et al. Before 2016, Australian law considered cannabis an illegal drug.

Research and Development 52

Research and Development Medicine Access Media 52

Veriheal

OCTOBER 5, 2020

The qualifying conditions for medical cannabis has been established in the bill as follows: Amyotrophic Lateral Sclerosis (ALS), Cachexia, Cancer, Chronic Pain, Crohn’s Disease, Epilepsy, Glaucoma, HIV/Aids, Lupus, Multiple Sclerosis, Nausea, Persistent Muscle Spasms, Post-traumatic Stress Disorder (PTSD), Rheumatoid Arthritis. .

Edibles 52

Edibles Legalization Decriminalization Consumption 52

Dykema (Cannabis Law Blog)

MARCH 25, 2020

According to state-released data, those patients purchased approximately $1.7 Unlike 18 of the 23 jurisdictions who have medical marijuana statutes , an individual cannot qualify for a registry identification card in Illinois if they have only “chronic pain.” At that point, Illinois had roughly 3,300 patients.

Chronic Pain 40

Chronic Pain Conditions Patients CBD 40

Cannabis Law Report

JUNE 30, 2019

Lou Correa (D-CA) that would require the VA to conduct clinical trials on the therapeutic potential of cannabis in the treatment of such service-related conditions as post-traumatic stress disorder and chronic pain. The results were published in May in the American Journal of Drug and Alcohol Abuse.

Chronic Pain 40

Chronic Pain Legislation Treatment Programs 40

MMJ Recs

MAY 3, 2024

The Arkansas medical marijuana program, established through the Arkansas Medical Marijuana Amendment in 2016, has paved the way for patients suffering from a variety of debilitating conditions to find relief and improved quality of life.

Marijuana 52

Marijuana Treatment Compliance Compliance 52

PrestoDoctor

SEPTEMBER 6, 2023

Codeine works by binding to opioid receptors in the brain, blocking pain signals and providing a sense of relief. Traditionally, prescription codeine has been prescribed for a variety of conditions, including post-operative pain, dental procedures, and chronic pain.

Chronic Pain 105

Chronic Pain Research and Development Patients Cannabis 105

Healer

MARCH 26, 2021

That is, until a “forward-thinking” primary care physician suggested medical cannabis for his chronic pain, which Gresh, 54, said set him on a new path that has changed his life for the better and helped him stop using virtually all drugs classified as highly addictive. . “I I never thought that would have been possible,” he said. “I

Chronic Pain 86

Chronic Pain Clinical Trials Treatment Patients 86

MassRoots

MARCH 8, 2019

Women who consume cannabis before sex have better orgasms than those who do not, according to new data. Aiming to examine how women interpret a sexual experience when cannabis has been consumed before hand, this study analyzes first-hand reports about: Overall sexual satisfaction Sex drive Orgasm Dyspareunia (pain during sex) Lubrication. “I

Data 112

Data Chronic Pain Medicine Patients 112

Veriheal

MAY 31, 2022

According to data released by the Centers for Disease Control and Prevention , there were an estimated 2,620 opioid overdose deaths in Texas between Aug. For too long, America has relied too heavily on opioids for pain relief. A Better Alternative for Chronic Pain. The Opioid Problem.

Programs 52

Programs Chronic Pain Treatment Conditions 52

Cannabis Law Report

AUGUST 22, 2021

Patent Office between December 20, 2016 and June 29, 2021. The first patent was granted near the end of 2016. 2016) | Ecuadorian Sativa. The data for the comparative study is in Table 2. The data for the comparative study is shown in Table 2 below. For more information about plant patents, click here.

Sativa 105

Sativa Indica Hybrid Ruderalis 105

The Cannigma

APRIL 8, 2021

CP: I’m going to say yes and it’s hard to tie this together, but there’s actually some really good animal, and a little bit of human data to support this. I postulate that that is correlated to our endocannabinoid system, which good data is now suggesting, is dysregulated in metabolic syndrome: obesity, diabetes, heart disease.

Medicine 108

Medicine Cannabinoids Cannabis THC 108

The Cannigma

JANUARY 13, 2023

The authors noted that while “promising data are emerging on the possible role of ECS in migraine…proper placebo-controlled trials are needed to establish a therapeutic role for cannabinoids.” 1 A 2008 study found serotonin and endocannabinoid levels, including anandamide, were lower in people with chronic migraines.

Terpenes 132

Terpenes Strains THC Treatment 132

SpeedWeed

MARCH 6, 2021

Florida for Care Executive Director Ben Pollara, the legalization advocate who helped lead Florida’s successful medical marijuana campaign in 2016, pointed out another problem in a recent op-ed published in the Fort Myers News-Press. Forcing patients to purchase more. Florida State Sen. Another way to prohibit cannabis.

THC 40

THC Patients Law Chronic Pain 40

Cannabis Law Report

JULY 30, 2019

The ASA highlights that it takes the FDA “an average of 9 years to approve any drug, but it only takes approximately two to four weeks for a medical cannabis patient with chronic pain to be approved by a state program.” ” They have a dedicated “End Pain, Not Lives.”

Marijuana 40

Marijuana Education Patients Research and Development 40

Cannabis Law Report

JULY 24, 2022

The market research company Data Bridge Market Research projects that the market capitalization of the psychedelic industry will grow 16.8 Of particular note are conditions such as cancer and multiple sclerosis, where cannabis-based medicines can alleviate chronic pain. Zurich 2016, Art. percent annually to $9.8

Research and Development 52

Research and Development Legalization Treatment Patients 52

Green Relief

MAY 13, 2018

In 2016, scientists at the University of Nottingham ( UK ) reported that CBD protects the blood-brain barrier from ischemia-induced oxygen and glucose deprivation by activating the 5- HT1A serotonin receptor and the PPAR -gamma nuclear receptor. Hypothermia is typically the go-to therapy for treating newborn infants after a stroke.

THC 64

THC CBD Cannabinoids Research and Development 64